Read + Share
Amedeo Smart
Independent Medical Education
Rossari F, Tada T, Suda G, Shimose S, et al. alpha-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. Int J Cancer 2023 Nov 23. doi: 10.1002/ijc.34799.PMID: 37994647
Email
LinkedIn
Facebook
Twitter
Privacy Policy